These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 8340900)
1. Cellular immune response to SIVmac and HIV-2 in macaques: model for the human HIV-1 infection. Voss G; Hunsmann G J Acquir Immune Defic Syndr (1988); 1993 Sep; 6(9):969-76. PubMed ID: 8340900 [TBL] [Abstract][Full Text] [Related]
2. Early helper T-cell dysfunction in simian immunodeficiency virus but not in human immunodeficiency virus type-2-infected macaques. Dittmer U; Lüke W; Stahl-Hennig C; Coulibaly C; Petry H; Bodemer W; Hunsmann G; Voss G J Med Primatol; 1994 Jul; 23(5):298-303. PubMed ID: 7869358 [TBL] [Abstract][Full Text] [Related]
3. Long-term non-progressive human immunodeficiency virus infection: new insights from the simian immunodeficiency virus model. Dittmer U; Hunsmann G J Gen Virol; 1997 May; 78 ( Pt 5)():979-84. PubMed ID: 9152413 [No Abstract] [Full Text] [Related]
4. MHC-I non-restricted cytotoxic activity in Macaca sylvana experimentally inoculated with HIV2 and SIV/mac. Charaf B; Sanhadji K; Sekkat S; Farouqui B; Touraine JL; Benslimane A Thymus; 1993 Aug; 22(1):1-12. PubMed ID: 7905683 [TBL] [Abstract][Full Text] [Related]
5. Vaccination with the Conserved Caveolin-1 Binding Motif in Human Immunodeficiency Virus Type 1 Glycoprotein gp41 Delays the Onset of Viral Infection and Provides Partial Protection in Simian/Human Immunodeficiency Virus-Challenged Cynomolgus Macaques. Hovanessian AG; Soundaramourty C; Benferhat R; Le Grand R; Dereuddre-Bosquet N; Krust B; Estaquier J J Virol; 2018 Sep; 92(18):. PubMed ID: 29976675 [TBL] [Abstract][Full Text] [Related]
6. Mechanisms of protection against simian immunodeficiency virus infection. Johnson RP Vaccine; 2002 May; 20(15):1985-7. PubMed ID: 11983259 [TBL] [Abstract][Full Text] [Related]
7. Cell-mediated immune response of macaques immunized with low doses of simian immunodeficiency virus (SIV). Dittmer U; Spring M; Petry H; Nisslein T; Rieckmann P; Lüke W; Stahl-Hennig C; Hunsmann G; Bodemer W J Biotechnol; 1996 Jan; 44(1-3):105-10. PubMed ID: 8717393 [TBL] [Abstract][Full Text] [Related]
8. Development of virus-specific immune responses in SHIV(KU)-infected macaques treated with PMPA. Kumar A; Buch S; Foresman L; Bischofberger N; Lifson JD; Narayan O Virology; 2001 Jan; 279(1):97-108. PubMed ID: 11145893 [TBL] [Abstract][Full Text] [Related]
9. Protection of human immunodeficiency virus type 2-exposed seronegative macaques from mucosal simian immunodeficiency virus transmission. Putkonen P; Mäkitalo B; Böttiger D; Biberfeld G; Thorstensson R J Virol; 1997 Jul; 71(7):4981-4. PubMed ID: 9188561 [TBL] [Abstract][Full Text] [Related]
11. Functional analyses of natural killer cells in macaques infected with neurovirulent simian immunodeficiency virus. Shieh TM; Carter DL; Blosser RL; Mankowski JL; Zink MC; Clements JE J Neurovirol; 2001 Feb; 7(1):11-24. PubMed ID: 11519478 [TBL] [Abstract][Full Text] [Related]
12. Immunological changes in simian immunodeficiency virus (SIV(agm))-infected African green monkeys (AGM): expanded cytotoxic T lymphocyte, natural killer and B cell subsets in the natural host of SIV(agm). Holznagel E; Norley S; Holzammer S; Coulibaly C; Kurth R J Gen Virol; 2002 Mar; 83(Pt 3):631-640. PubMed ID: 11842258 [TBL] [Abstract][Full Text] [Related]
13. Comparative evaluation of simian, simian-human, and human immunodeficiency virus infections in the pigtail macaque (Macaca nemestrina) model. Batten CJ; De Rose R; Wilson KM; Agy MB; Chea S; Stratov I; Montefiori DC; Kent SJ AIDS Res Hum Retroviruses; 2006 Jun; 22(6):580-8. PubMed ID: 16796533 [TBL] [Abstract][Full Text] [Related]
14. Similar abnormalities of idiotype and immunoglobulin light chain expression and of cell-mediated cytotoxicity in HIV-infected humans and simian immunodeficiency virus (SIV)-infected rhesus macaques. Grant MD; Whaley MD; Mayne A; Hoffmann GW; Ansari AA Immunol Cell Biol; 1996 Feb; 74(1):38-44. PubMed ID: 8934652 [TBL] [Abstract][Full Text] [Related]
15. Th17 cells in pathogenic simian immunodeficiency virus infection of macaques. Cecchinato V; Franchini G Curr Opin HIV AIDS; 2010 Mar; 5(2):141-5. PubMed ID: 20543591 [TBL] [Abstract][Full Text] [Related]
16. Repeated exposure of rhesus macaques to low doses of simian immunodeficiency virus (SIV) did not protect them against the consequences of a high-dose SIV challenge. Dittmer U; Stahl-Hennig C; Coulibaly C; Nisslein T; Lüke W; Fuchs D; Bodemer W; Petry H; Hunsmann G J Gen Virol; 1995 Jun; 76 ( Pt 6)():1307-15. PubMed ID: 7782761 [TBL] [Abstract][Full Text] [Related]
17. Protection against chronic infection and AIDS by an HIV envelope peptide-cocktail vaccine in a pathogenic SHIV-rhesus model. Nehete PN; Chitta S; Hossain MM; Hill L; Bernacky BJ; Baze W; Arlinghaus RB; Sastry KJ Vaccine; 2001 Dec; 20(5-6):813-25. PubMed ID: 11738745 [TBL] [Abstract][Full Text] [Related]
19. Immunization with virion-derived glycoprotein 130 from HIV-2 or SIV protects macaques against challenge virus grown in human or simian cells or prepared ex vivo. Stahl-Hennig C; Coulibaly C; Petry H; Voss G; Dittmer U; Bodemer W; Makoschey B; Jurkiewicz E; Lüke W; Hunsmann G AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S27-32. PubMed ID: 7865316 [TBL] [Abstract][Full Text] [Related]
20. Immunization of macaques with live simian human immunodeficiency virus (SHIV) vaccines conferred protection against AIDS induced by homologous and heterologous SHIVs and simian immunodeficiency virus. Kumar A; Mukherjee S; Shen J; Buch S; Li Z; Adany I; Liu Z; Zhuge W; Piatak M; Lifson J; McClure H; Narayan O Virology; 2002 Sep; 301(2):189-205. PubMed ID: 12359422 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]